Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis for you to read. Along with our medical data and news we also list A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis Clinical Trials, which are updated daily. BioPortfolio also has a large database of A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis Companies for you to search.
SeqOnce Biosciences Inc. launches its new RhinoSeq™ DNA Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. PASADENA, Calif. (PRWEB) March 22, 2019 SeqOnce Biosciences Inc. launches its new RhinoSeq™ DNA Library Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary kit chemistry that makes it the fastest DNA librar...
[Articles] Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial
Monthly intermittent preventive treatment with dihydroartemisinin–piperaquine was safe but did not lead to significant improvements in birth outcomes compared with sulfadoxine–pyrimethamine.
Long-term treatment with β blockers could increase decompensation-free survival in patients with compensated cirrhosis and CSPH, mainly by reducing the incidence of ascites.
An ultrarestrictive opioid prescription protocol radically reduces postoperative opioid use in patients with gynecological cancer who do not have compromising outcomes. Medscape Medical News
Lucemyra is the First FDA Approved Medicine to Treat Opioid Withdrawal Syndrome (OWS). GREAT NECK. N.Y. (PRWEB) March 22, 2019 “Not a day goes by when we don’t learn more about the devastation caused by opioid addiction. Every day in the United States approximately 4,000 individuals start using opiates for non-medical purposes. We are now up to about 130 opioid overdoses per day,” says Neur...
$BIIB double downgraded to Underweight at MS. PT $210 from $401
LILLE, France, March 22, 2019 / B3C newswire / -- ALZPROTECT, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer's disease, today announced that PAREXEL Biotech, a new division of PAREXEL International Corporation, has been selected to perform the clinical phase 2a development of
Using their extensive proprietary data sources, Covance guided an emerging pharmaceutical company who was uncertain about how to balance the selection of the right patients for their trial endpoints with the ability to achieve rapid patient recruiting.
(JAMA Network) Financial incentives didn't increase completion rates of colorectal cancer screening tests mailed to patients. In a randomized clinical trial of almost 900 patients, none of the incentives (an unconditional $10, a promised $10 upon completion of the fecal immunochemical test (FIT) kit to test for blood in a stool sample or chance at a lottery with a 1-in-10 chance of winning $100) w...
Attained multiple milestones in DECIDE1/2 clinical program in advanced ovarian cancer Achieved initial positive data from phase 2 clinical trial in DLBCL with Merck Initiated a phase 2 basket trial across five indications under a collaboration with Merck Listed on Nasdaq and changed Corpora...
Families randomized to working with a 2-1-1 coordinator were more likely to receive developmental screening, referral and services.
HANGZHOU, China, March 21, 2019 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye"), a global clinical-stage biopharmaceutical company today announced that it has received a clearance from the National Medical Products Administration (NMPA) of China for initiating the open-label, randomized, multicenter, global phase III clinical trial for pelareorep (AN1004) in combination with pacl...
Executed strategic agreement for Imeglimin with Roivant Sciences; potential for up to USD 600 million in regulatory and development milestone payments and sales-based payments plus royalties on net sales Roivant concurrently invested USD 15 million (approximately EUR 12 million) in Poxel through subscription in newly-issued ordinary ...
Dr. Richard Amato and Dr. Michael Kang welcome patients with missing teeth and/or loose dentures in Waterbury, CT for an All-on-4® full arch dental implants consultation. Drs. Amato and Kang practice periodontology and implantology in Monroe, CT, serving patients from Trumbull, Shelton, Danbury, Newtown, and Waterbury, CT. Waterbury, CT (PRWEB) March 21, 2019 Patients with missing teeth or t...
Dan Jeffries was diagnosed with ultra-rare Wyburn-Mason syndrome at a young age, leaving him blind in one eye. This was compounded when he found he was living with not one, but two rare conditions, complicating treatment and leading to some close calls h
Dan Jeffries was diagnosed with ultra-rare Wyburn-Mason syndrome at a young age, leaving him blind in one eye. This was compounded when he found he was living with not one, but two rare conditions, complicating treatment and leading to some close calls http://bit.ly/2HBAgay pic.twitter.com/dROXn9qzsc
Intelligent Waves LLC, an end-to-end information technology solutions provider, today announced that it was awarded a $2.9 million task order to deliver information technology support to the Department of Veterans Affairs (VA). Enabling efficient and effective care of veterans, the task order – awarded under VA’s Transformation Twenty-One Total Technol...
Diabetic macular edema (DME) is the most common condition that contributes to vision loss in persons with diabetes. PhotoOpTx, LLC has entered into an agreement with the Jaeb Center for Health Research Foundation acting on the behalf of the DRCR Network to provide devices for "A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema". SOLON, Ohio (PRWEB) March 21, 2...
Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab.
Could your next surgery be done by a robot? With procedure volumes rising, there’s a good chance that this will be the case. Mirroring the quick-paced nature of new technological innovations, the surgical robotics market has experienced significant prosperity recently, which is expected to continue through 2025. Currently valued at over $3 billion, this ...
The King’s Fund think-tank has claimed that in the next five years nurse shortages will double and GP gaps could potentially nearly triple to 7,000.
THURSDAY, March 21, 2019 -- Only a small proportion of recommendations in major cardiovascular society guidelines are supported by evidence from multiple randomized controlled trials (RCTs) or a single large RCT, according to a study published in...
ZipLine Medical, Inc. today announced presentation of positive results from a randomized, prospective clinical study conducted at the Karolinska University Hospital in Stockholm, Sweden demonstrating both clinical and economic benefits of the Zip® Surgical Skin Closure device when used in an emergency medicine setting for lacerations. A poster...
The Serious Illness Care Program helps oncologists have better serious-illness conversations with patients without creating anxiety or depression, according to results of a cluster-randomized clinical trial. Reuters Health Information
Danish pharma group awaits decision on oral diabetes drug and Ozempic
A special symposium session, intended to highlight therapeutic advances, will focus on Tumor Treating Fields as a fourth modality in cancer treatment The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at this conference Novocure (NASDAQ: NVCR) announced today 48 presentations on Tumor Treat...